Genomic testing in prostate cancer and personalized medicine

“The…state of genomic testing continues to evolve,” says Ketan K. Badani, MD.

In this video, Ketan K. Badani, MD, also shares what personalized medicine means to him. Badani is a professor of urology at Icahn School of Medicine at Mount Sinai, vice chairman of urology and robotic operations at Mount Sinai Health System, director of robotic surgery at Mount Sinai West, and the director of the Comprehensive Kidney Cancer Program At Mount Sinai Health System, New York.